深市港股通前十大成交活跃股中，成交额居首的是晶泰控股，成交金额21.30亿港元；其次是阿里巴巴- W、美团-W，成交金额分别为20.54亿港元、18.55亿港元。以净买卖金额统计，有7只股为净买入，净 买入金额最多的是腾讯控股，净买入8.00亿港元，该股收盘上涨1.70%。净卖出金额最多的是美团-W， 净卖出3.84亿港元，收盘股价下跌1.46%。（数据宝） 8月6日港股通成交活跃股 | 代码 | 简称 | 类型 | 成交金额（万港元） | 成交净买入（万港元） | 日涨跌幅（%） | | --- | --- | --- | --- | --- | --- | | 00700 | 腾讯控股 | 港股通(沪) | 455358.46 | 71753.88 | 1.70 | | 02228 | 晶泰控股 | 港股通(沪) | 451811.07 | 47520.46 | 12.42 | | 09988 | 阿里巴巴-W | 港股通(沪) | 316394.87 | 67793.11 | 0.60 | | 00981 | 中芯国际 | 港股通(沪) | 233003.74 | 36379.08 | 3.14 | | ...

成交活跃股方面，今日上榜个股中，南向资金成交金额最多的是晶泰控股，合计成交额66.48亿港元， 腾讯控股、阿里巴巴-W成交额紧随其后，分别成交63.65亿港元、52.18亿港元。以净买卖金额统计，净 买入的个股共有7只，腾讯控股净买入额为15.18亿港元，净买入金额居首，该股收盘股价上涨1.70%， 阿里巴巴-W净买入额为8.76亿港元，中芯国际净买入额为6.12亿港元。净卖出金额最多的是小米集团- W，净卖出2.29亿港元，该股收盘股价下跌0.55%，泡泡玛特、美团-W遭净卖出2.23亿港元、1.48亿港 元。 8月6日恒生指数上涨0.03%，南向资金全天合计成交金额为1259.74亿港元，其中，买入成交677.30亿港 元，卖出成交582.44亿港元，合计净买入金额94.85亿港元。具体来看，港股通（深）累计成交金额 471.73亿港元，买入成交260.95亿港元，卖出成交210.78亿港元，合计净买入金额50.16亿港元；港股通 （沪）累计成交金额788.01亿港元，买入成交416.35亿港元，卖出成交371.66亿港元，合计净买入金额 44.69亿港元。 从连续性进行统计， 有4只股获南向资金连续3天 ...

今晚，话题"美团 霸王茶姬"登上微博热搜，原因是有大量网友称通过美团"神抢手"活动领取的霸王茶 姬"伯牙绝弦"兑换券，在短时间内被系统强制收回。对此，美团外卖在官方微博回应称，"原本，我们 和霸王茶姬正在为大家准备秋天的第一杯好茶，今天请可爱的骑手们先喝时，手一抖，提前发给了大 家。既然提前发了，那我们就先喝起来吧。从现在开始，所有领取到霸王茶姬茶饮券的朋友，到8月10 日前，可以到全国外卖门店兑换相应茶饮。" ...

Core Viewpoint - Meituan is launching a promotional campaign to celebrate the beginning of autumn by providing free milk tea to its delivery riders, highlighting its commitment to employee welfare and engagement [1] Group 1: Promotional Activities - Meituan will distribute 2.7 million cups of new milk tea vouchers to all riders who have completed deliveries recently, allowing them to enjoy the drink or share it with friends and family [1] - In addition to the milk tea, Meituan will offer over 10,000 free "relaxation therapy vouchers" for well-known tea brands across more than ten cities, enabling frontline employees to enjoy 40 to 60 minutes of free foot massages and other relaxation services [1] Group 2: Additional Benefits - Beyond the autumn milk tea initiative, Meituan will provide an extra cup of milk tea to over 100,000 riders with a safety score of five or above in cities like Dalian, Shenyang, Wuhan, Guiyang, Haikou, Nanchang, and Hangzhou [1] - The company will also enhance its long-term benefits for riders, including ice drink vehicles, station gatherings, summer support, and the "Rider Home" program, which will be rolled out alongside the autumn milk tea benefits [1]

Core Viewpoint - The launch of the innovative insomnia drug, Lemborexant (brand name: Davaiq), on Meituan marks a significant development in the treatment options available for insomnia patients in China, particularly as it is the first approved dual orexin receptor antagonist that is not classified as a controlled substance [1][2]. Group 1: Product Overview - Lemborexant is designed to treat adult patients with insomnia characterized by difficulties in falling asleep and/or maintaining sleep, and it has not been found to have addictive properties since its market introduction [1]. - The drug was approved by the National Medical Products Administration in May 2023 and is reported to shorten sleep onset time, reduce nighttime awakenings, and extend total sleep time, positively affecting sleep structure [1][2]. Group 2: Market Context - According to the "2025 China Sleep Health Survey Report," approximately 485 million people in China suffer from sleep-related issues, highlighting a significant market opportunity for insomnia treatments [1]. - Prior to Lemborexant, insomnia medications were primarily classified as controlled substances, which limited treatment options for patients [1]. Group 3: Clinical and Regulatory Insights - Clinical trials indicate that Lemborexant has minimal impact on memory and cognitive function, allowing patients to resume daily activities, including driving, without significant impairment [2]. - The drug has been included in the "Chinese Adult Insomnia Diagnosis and Treatment Guidelines (2023 Edition)" as an IA-level recommendation, further validating its clinical efficacy [2]. Group 4: Distribution and Accessibility - Meituan has facilitated the purchase of Lemborexant through its platform, allowing patients to order the medication with a prescription and receive it via home delivery within 48 hours, with compensation offered for any delays [2]. - The trend of online platforms becoming significant channels for new drug purchases is growing, with Meituan having launched seven new drugs since last year, covering various therapeutic areas including GLP-1, myopia, gout, and insomnia [2].

【#美团回应回收茶饮券#】@美团外卖 发文回应网传回收茶饮券称：原本，我们和@霸王茶姬 CHAGEE 正在为大家准备秋天的第一杯好茶，今天请可爱的骑手们先喝时，手一抖，提前发给了大 家。既然提前发了，那我们就先喝起来吧，一起先甜！#美团 霸王茶姬# ...

Group 1 - The core activity involves Meituan distributing approximately 2.7 million cups of milk tea to its delivery riders as a promotional event ahead of the autumn season, coinciding with a peak in milk tea orders [2] - The event is part of a broader initiative to provide welfare and support to riders, including activities in over 20 cities such as Beijing and Shanghai, where riders can receive milk tea and other benefits [2][5] - Riders are encouraged to participate in various summer activities, which include receiving cooling supplies and engaging in community events, regardless of their rider type or uniform [2][5] Group 2 - Meituan is also implementing safety incentives, offering free milk tea to over 100,000 riders who maintain a safety rating of five or above, along with cash rewards for safe deliveries [5] - The company has launched a comprehensive support system for riders, including the distribution of 3 million free heatstroke prevention insurance policies and the introduction of social security benefits, which are expected to cover over one million riders by the end of the year [6] - Meituan is committed to enhancing rider safety and welfare through various initiatives, including the establishment of "Rider Homes" for training and support, and the creation of the "Tongzhou Fund" for financial assistance to riders and their families [6]

Group 1 - The core viewpoint is that with the increasing health awareness among the public, there is a growing demand for oral management and myopia correction services, as evidenced by a 45% year-on-year increase in search volume for keywords like "teeth correction" and "myopia surgery" since July, and over 60% growth in orders for dental clinics and ophthalmology institutions [2] - Meituan Health has launched the "Worry-Free Purchase" campaign in August, collaborating with over 20,000 dental and ophthalmology institutions to provide benefits for parents with school-age children, including services like vision tests and fluoride treatments [2] - The campaign also features a dedicated knowledge section on children's oral and eye health protection, developed in partnership with well-known brands, aimed at educating parents on comprehensive health service options for their children [2] Group 2 - The National Health Commission has been promoting initiatives for the prevention of myopia and oral health among infants, children, and adolescents, with some cities including dental treatments in medical insurance pilot programs [3] - The adoption of advanced technologies such as femtosecond lasers and digital orthodontics has lowered psychological barriers for consumers, making health services more accessible [3] - Meituan's recent collaboration with leading dental and ophthalmology brands aims to provide affordable and professional health services for young people and their families [3]

8月6日，立秋前夕，全国百万美团骑手收到"秋天第一杯奶茶"。记者联系到美团相关负责人，对方证实，美团联合二十多家头部茶饮品牌，共计发放约270 万杯奶茶，近期在美团配送完成过订单的骑手都可获得，由于短时发放量级较大，目前还在分批推送中。同日，在北京、上海、长沙等20多座城市，美团在 骑手之家、核心商圈、骑手站点等多场景举办活动，现场为骑手送出奶茶，开展互动体验送福利。 型 中 区 Eall CD 2:30 E ENA 影美团外家 切系券已发放 去享用 条爱的骑手: 秋奶即将忙碌起来，您已收到用户点赞！今 1 B 这杯知东，请您先"甜",让我们一起云碰 1 杯吧! 辛苦啦! E 照明 易美国外交 美团联合二十多家头部茶饮品牌，共计发放约270万杯奶茶。摄影：李大金 "平时都是我给别人送奶茶，没想到这次给我'送'奶茶，这是我第一次喝霸王茶姬，这个福利很惊喜。"在北京朝阳大悦城的快闪活动现场，骑手米成杰说 道。来自河南的米成杰，来北京已经八年了，目前在美团担任乐跑骑士长，而在美团当骑手的这份工作，也给他的生活带来了巨大的变化。 "我之前干过厨师，还卖过服装，做过销售，后来了解到外卖骑手收入高，我就来北京了，试了试几 ...

| 公司名称 | 成交金额 | 净买入额 | | --- | --- | --- | | 晶泰控股(02228) | 21.30 亿元 | +5750.15 万元 | | 阿里巴巴-W(09988) | 20.54 亿元 | +1.98 亿元 | | 美团-W(03690) | 18.55 亿元 | -3.84 亿元 | | 腾讯控股(00700) | 18.12 亿元 | +8.00 亿元 | | 理想汽车-W(02015) | 13.94 亿元 | -3918.97 万元 | | 泡泡玛特(09992) | 13.49 亿元 | +8996.36 万元 | | 中芯国际(00981) | 12.78 亿元 | +2.48 亿元 | | 小米集团-W(01810) | 10.05 亿元 | -1.44 亿元 | | 比亚迪电子(00285) | 9.79 亿元 | +2.18 亿元 | | 康方生物(09926) | 7.28 亿元 | +1.38 亿元 | | 公司名称 | 成交金额 | 净买入额 | | --- | --- | --- | | 腾讯控股(00700) | 45.54 亿元 | +7.18 ...